E
Elena Gospodarevskaya
Researcher at Deakin University
Publications - 35
Citations - 1785
Elena Gospodarevskaya is an academic researcher from Deakin University. The author has contributed to research in topics: Cost effectiveness & Population. The author has an hindex of 15, co-authored 35 publications receiving 1655 citations. Previous affiliations of Elena Gospodarevskaya include Monash University & Liverpool School of Tropical Medicine.
Papers
More filters
Journal ArticleDOI
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation
Joanna Picot,Jeremy Jones,JL Colquitt,Elena Gospodarevskaya,Emma Loveman,L Baxter,Andrew Clegg +6 more
TL;DR: Bariatric surgery was a more effective intervention for weight loss than non-surgical options and there was higher remission of Type 2 diabetes than in non-Surgical groups.
Journal ArticleDOI
Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation.
Andrea Takeda,Keith Cooper,A Bird,L Baxter,Geoff K Frampton,Elena Gospodarevskaya,Kathy M. Welch,Jackie Bryant +7 more
TL;DR: The clinical effectiveness and cost-effectiveness of rhGH compared with treatment strategies without rhGH for children with GHD, TS, PWS, CRI, SGA and SHOX-D and those born SGA is assessed.
Journal ArticleDOI
A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting
TL;DR: Although some of the results suggest that methadone may have a cost advantage, it is difficult to infer from the trial data that offering buprenorphine as an alternative would have a significant effect on total costs or outcomes.
Journal ArticleDOI
The safety and effectiveness of different methods of earwax removal: a systematic review and economic evaluation
Andrew Clegg,Emma Loveman,Elena Gospodarevskaya,P Harris,A Bird,Jackie Bryant,David Scott,Peter Davidson,Paul Little,Richard Coppin +9 more
TL;DR: An evidence synthesis of the clinical effectiveness and cost-effectiveness of the interventions currently available for softening and/or removing earwax and any adverse events (AEs) associated with the interventions is conducted.
Journal ArticleDOI
Ustekinumab for the treatment of moderate to severe psoriasis.
TL;DR: The manufacturer's economic model of treatments for psoriasis compared ustekinumab with other biological therapies used a reasonable approach; however, it is not clear whether the clinical effectiveness estimates from the subgroup analysis, used in the base-case analysis, were methodologically appropriate.